Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: an emerging need for novel drug delivery systems
Oxidative stress is intensely involved in enhancing the severity of various chronic respiratory
diseases (CRDs) including asthma, chronic obstructive pulmonary disease (COPD) …
diseases (CRDs) including asthma, chronic obstructive pulmonary disease (COPD) …
Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell
Lung Cancer (NSCLC) provide recommended management for patients with NSCLC …
Lung Cancer (NSCLC) provide recommended management for patients with NSCLC …
[HTML][HTML] Skin problems and EGFR-tyrosine kinase inhibitor
T Kozuki - Japanese journal of clinical oncology, 2016 - ncbi.nlm.nih.gov
Epidermal growth factor receptor inhibition is a good target for the treatment of lung, colon,
pancreatic and head and neck cancers. Epidermal growth factor receptor-tyrosine kinase …
pancreatic and head and neck cancers. Epidermal growth factor receptor-tyrosine kinase …
Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology
This selection from the NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC)
focuses on targeted therapies and immunotherapies for metastatic NSCLC, because …
focuses on targeted therapies and immunotherapies for metastatic NSCLC, because …
Non–small cell lung cancer, version 6.2015
These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for
Non–Small Cell Lung Cancer (NSCLC). Appropriate targeted therapy is very effective in …
Non–Small Cell Lung Cancer (NSCLC). Appropriate targeted therapy is very effective in …
NCCN guidelines® Insights: non–small cell lung cancer, version 2.2023: featured updates to the NCCN guidelines
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) provide recommendations
for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus …
for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus …
Non–small cell lung cancer, version 1.2015
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Non-Small Cell Lung Cancer (NSCLC) focuses on the principles of radiation therapy …
for Non-Small Cell Lung Cancer (NSCLC) focuses on the principles of radiation therapy …
Molecular mechanisms and targeted therapies including immunotherapy for non-small cell lung cancer
T Nagano, M Tachihara… - Current cancer drug …, 2019 - ingentaconnect.com
Lung cancer is the leading cause of cancer death worldwide. Molecular targeted therapy
has greatly advanced the field of treatment for non-small cell lung cancer (NSCLC), which …
has greatly advanced the field of treatment for non-small cell lung cancer (NSCLC), which …
Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapy
M Saito, H Suzuki, K Kono, S Takenoshita, T Kohno - Surgery today, 2018 - Springer
Lung adenocarcinoma (LADC) is a cancer treatable using targeted therapies against driver
gene aberrations. EGFR mutations and ALK fusions are frequent gene aberrations in LADC …
gene aberrations. EGFR mutations and ALK fusions are frequent gene aberrations in LADC …
Non–Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell
Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC …
Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC …